Today news
About the same in other media
UK biotech firm Aptamer to float valued at £80.7m
Reading now: 682
A British biotechnology firm that supplies big pharmaceutical firms with synthetic antibodies for targeted delivery of drugs will float in London this week valued at £80.7m – giving its two founders a combined paper fortune of more than £33m.
Aptamer Group was founded in 2008 by Dr Arron Tolley, 34, an early school leaver who later completed a doctorate in biophysics and molecular biology, and Dr David Bunka, a geneticist. Today, the York-based company has partnerships with the vast majority of the world’s top 20 pharmaceutical firms, including Britain’s biggest drugmaker, AstraZeneca, and Japan’s Takeda.
When the two founders first met at Leeds University, Tolley was doing a PhD in virology, studying DNA packaging mechanisms in viruses. “We
Read more on theguardian.comAbout this in other media
Pentagon denies Russian allegations that US firms are sending 'chemical components' into Ukraine euronews.com /2 years ago
EU firms shun UK’s post-Brexit permissions in ‘ominous’ sign fnlondon.com /3 years ago
Takeover regulator extends deadline for offers on River & Mercantile, firm says fnlondon.com /3 years ago
Show more
The website finance-news.co. is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
